Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The quest to understand and slow disease ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis.

On Tuesday, Nov. 5, as part of the Johns Hopkins Medicine’s Department of Neurology and Neurosurgery Neuroimmunology Seminar Series, Dr. Amber Salter delivered an overview of her ongoing work ...

(Science) A case report assessed the effect of continuous exposure to ofatumumab (Kesimpta) during pregnancy in a patient ...

Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader ... and remain an important unmet ...

The findings are published in The Lancet Neurology. “Fatigue is one of the most common and debilitating symptoms of multiple sclerosis, yet there is still uncertainty about how available ...

For columnist Susan Payrovi, music and dance are key to connecting with others and living a joyful life with multiple ...

The following is a summary of “A qualitative study on the experiences of autologous haematopoietic stem cell transplant for Multiple Sclerosis,” published in the November 2024 issue of Neurology by ...

The following is a summary of “Assessing and tailoring predictive equations of VO2 max for women with multiple sclerosis with ...

In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

The findings are published in The Lancet Neurology. "Fatigue is one of the most common and debilitating symptoms of multiple sclerosis, yet there is still uncertainty about how available ...